Shares Investor Evening (Edinburgh) - 21 September 2017

Come and celebrate 6 years of investor evenings with Shares and AJ Bell Media on 21 September in Edinburgh and receive a Shares goody bag worth over £150!

We cant believe that 6 years have passed since we started our investor evenings, in that time many 1000s of private investors, fund managers, brokers and analysts have come along and heard from 100s of listed companies present their investment opportunity.

To celebrate our investor evening in Edinburgh on 21 September, we will give all attendees a free goody bag containing:

1. A one year subscription to Shares magazine digital. Each week you will receive the latest Shares digital weekly magazine where our team of experts will give you a multitude of investment ideas. You will also gain access to the Shares investor toolkit with live news, LIVE share prices, portfolio and research tools (value £120)

2. A bottle of champagne (value £20)

3. The DIY Investor book written by Andy Bell, CEO of AJ Bell (RRP £17.99)

On the evening hear from:

Corero Network Security (CNS) - Corero Network Security is the leader in real-time, high-performance DDoS defense solutions. Service providers, hosting providers and online enterprises rely on Coreros award winning technology to eliminate the DDoS threat to their environment through automatic attack detection and mitigation, coupled with complete network visibility, analytics and reporting. This next-generation technology provides a First Line of Defense® against DDoS attacks in the most complex environments while enabling a more cost effective economic model than previously available.

Midatech Pharma (MTPH) - Midatech is a nanomedicine company focused on the development and commercialisation of multiple, high-value, targeted therapies for major diseases with unmet medical need. It is advancing a pipeline of novel clinical and pre-clinical product candidates based on its proprietary drug conjugate and sustained release delivery platforms with a clear focus on the key therapeutic areas of diabetes, cancer and neuroscience/ophthalmology. Midatechs strategy is to develop its products in-house in rare cancers and with partners in other indications, and to accelerate growth of its business through strategic acquisition of complementary products and technologies.

NEX Exchange - NEX Exchange is used by entrepreneurs and individuals to manage their financial challenges. They give companies of all sizes, from micro to mid-caps, access to a public quote or a fully regulated listing. For investors, they offer simple access to a diverse range of dynamic, small and medium sized companies and to a variety of equity or debt products. For ambitious companies and investors, NEX Exchange is a platform for growth.